AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
129.18 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.39 2.50 3.53 3.26
P/FCF ratio
58.91 58.32 103.31 562.68
P/Operating CF
61.36 (345.09) 94.32 63.23
P/B ratio
2.64 2.80 3.84 3.54
Price to Tangible BV
5.71 6.53 9.03 8.82
EV/Sales
2.26 2.40 3.40 3.16
EV/EBITDA
37.60 72.75 157.03 0.00
EV/Operating CF
19.80 20.59 31.67 37.91
EV/FCF
55.62 56.05 99.30 544.89
Quick Ratio
3.02 2.97 2.87 2.71
Current Ratio
4.22 4.29 3.96 3.87
Net Debt/EBITDA
(6.42) (12.60) (12.19) (13.49)
Debt/Assets
10.50% 11.15% 11.22% 11.60%
Debt/Equity
0.14 0.15 0.15 0.15
Asset Turnover
0.89 0.89 0.85 0.83
Operating CF/Net income
2.48 (37.00) 11.40 (100.06)
Capex/Depreciation
(0.70) (0.72) (0.31) (0.49)
Interest Coverage
7.33 0.39 1.66 0.14
Research and Development Expense of Revenue
17.19% 17.16% 17.44% 17.05%
Selling, General and Administrative Expense of Revenue
53.75% 59.86% 55.76% 58.27%
Intangible Assets out of Total Assets
0.41 0.44 0.43 0.45
Share Based Compensation of Revenue
8.02% 7.98% 8.01% 9.25%
Graham Net Nets
0.14 0.12 0.08 0.08
Graham Number
7.19 0.00 0.00 0.00
Earnings Yield
0.77% (0.33%) (0.60%) (1.72%)
Free Cash Flow Yield
1.70% 1.71% 0.97% 0.18%
Revenue per Share
3.16 2.92 2.94 2.80
Operating CF per Share
0.46 (0.08) 0.42 0.56
Capex per Share
(0.08) (0.08) (0.03) (0.05)
Free Cash Flow per Share
0.38 (0.16) 0.39 0.50
Cash per Share
3.45 3.02 3.51 3.09
Shareholders Equity per Share
10.61 10.17 10.30 9.94
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
10.61 10.17 10.30 9.94
Free Cash Flow
18.43 (7.85) 18.43 24.11
Working Capital
263.62 240.50 241.00 223.27
Capital Expenditures
(3.77) (3.85) (1.60) (2.60)
Net Current Asset Value
185.32 161.40 160.27 142.18
EV/EBIT
99.74 0.00 0.00 0.00
Capex to Sales
0.02 0.03 0.01 0.02
Price to Operating Income
105.64 0.00 0.00 0.00
Other line items
Average Receivables
72.99 67.32 63.50 58.94
Average Payables
30.76 27.87 25.17 28.60
Average Inventory
80.13 78.03 76.91 77.75
Average Assets
642.75 617.81 631.75 625.26
Average Common Equity
490.46 473.16 476.45 470.76

Fold the line items

Columns are period end dates